| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Pathology and Immunology [M. A. W., A. P.], Medicine [V. B., C. H., W. D. S.], and Neurosurgery [K. M. R.], Washington University School of Medicine, St. Louis, Missouri 63110
Oligodendrogliomas are the second most common type of glial neoplasm with distinct prognostic and therapeutic implications. Although refinements have led to improved clinical stratification, current grading schemes are still limited by subjective histopathological criteria. In this report, we have used oligonucleotide array technology to perform expression profiling in morphologically classic oligodendrogliomas. Expression information from
1100 genes divided tumors into two molecularly distinct groups that corresponded exactly to their previously assigned histological grades. Subsequent gene clustering identified a subset of 196 transcripts showing a common, differential expression pattern between tumor grades. A number of these genes have been associated with the maintenance of cytoarchitecture, cellular differentiation and maturation, immunogenicity, and chemotherapeutic resistance. These results demonstrate the utility of gene expression profiling as an objective, ancillary tool for grading oligodendrogliomas and a potential approach for classifying diffuse gliomas where histological assessment may be difficult or ambiguous.
This article has been cited by other articles:
![]() |
P. J. French, S. M.A. Swagemakers, J. H.A. Nagel, M. C.M. Kouwenhoven, E. Brouwer, P. van der Spek, T. M. Luider, J. M. Kros, M. J. van den Bent, and P. A. Sillevis Smitt Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas Cancer Res., December 15, 2005; 65(24): 11335 - 11344. [Abstract] [Full Text] [PDF] |
||||
![]() |
Gene Expression Profiles of Oligodendrogliomas Cancer Res., October 1, 2005; 65(19): 9108 - 9108. [Full Text] [PDF] |
||||
![]() |
Y. Liang, M. Diehn, N. Watson, A. W. Bollen, K. D. Aldape, M. K. Nicholas, K. R. Lamborn, M. S. Berger, D. Botstein, P. O. Brown, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme PNAS, April 19, 2005; 102(16): 5814 - 5819. [Abstract] [Full Text] [PDF] |
||||
![]() |
L F Callado, J I Martin-Gomez, J Ruiz, J M Garibi, and J J Meana Imidazoline I2 receptor density increases with the malignancy of human gliomas J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 785 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Khodarev, J. Yu, E. Labay, T. Darga, C. K. Brown, H. J. Mauceri, R. Yassari, N. Gupta, and R. R. Weichselbaum Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells J. Cell Sci., March 15, 2003; 116(6): 1013 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Greenberg, D. Sanoudou, J. N. Haslett, I. S. Kohane, L. M. Kunkel, A. H. Beggs, and A. A. Amato Molecular profiles of inflammatory myopathies Neurology, October 22, 2002; 59(8): 1170 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Tseng, P. Zhao, J. S. Pattison, S. E. Gordon, J. A. Granchelli, R. W. Madsen, L. C. Folk, E. P. Hoffman, and F. W. Booth Regenerated mdx mouse skeletal muscle shows differential mRNA expression J Appl Physiol, August 1, 2002; 93(2): 537 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Watson, D. H. Gutmann, K. Peterson, M. R. Chicoine, B. K. Kleinschmidt-DeMasters, H. G. Brown, and A. Perry Molecular Characterization of Human Meningiomas by Gene Expression Profiling Using High-Density Oligonucleotide Microarrays Am. J. Pathol., August 1, 2002; 161(2): 665 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ramaswamy and T. R. Golub DNA Microarrays in Clinical Oncology J. Clin. Oncol., April 1, 2002; 20(7): 1932 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Magee, T. Araki, S. Patil, T. Ehrig, L. True, P. A. Humphrey, W. J. Catalona, M. A. Watson, and J. Milbrandt Expression Profiling Reveals Hepsin Overexpression in Prostate Cancer Cancer Res., August 1, 2001; 61(15): 5692 - 5696. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |